‘The waiting game’: are current chlamydia and gonorrhoea near-patient/point-of-care tests acceptable to service users and will they impact on treatment?

Mapping patient pathways and estimating resource use for point of care versus standard testing and treatment of chlamydia and gonorrhoea in genitourinary medicine clinics in the UK

(2014) E. J. Adams et al.   BMJ Open

A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities: Test, Treat ANd GO- the “TTANGO” trial protocol

(2013) Rebecca J Guy et al.   BMC INFECTIOUS DISEASES

Analytical Evaluation of GeneXpert CT/NG, the First Genetic Point-of-Care Assay for Simultaneous Detection of Neisseria gonorrhoeae and Chlamydia trachomatis

(2013) S. N. Tabrizi et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Performance of the Cepheid CT/NG Xpert Rapid PCR Test for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae

(2013) C. A. Gaydos et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Point-of-care tests for sexually transmissible infections: what do ‘end users' want?

(2013) Anne M. Rompalo et al.   Sexual Health

An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests forChlamydia trachomatisandNeisseria gonorrhoeain genitourinary medicine clinics in England

(2013) Katherine M E Turner et al.   SEXUALLY TRANSMITTED INFECTIONS

UK national guideline for the management of gonorrhoea in adults, 2011

(2011) C Bignell et al.   INTERNATIONAL JOURNAL OF STD & AIDS